Literature DB >> 21890762

Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.

Abhishek Deshpande1, Vinay Pasupuleti, David D K Rolston, Anil Jain, Narayan Deshpande, Chaitanya Pant, Adrian V Hernandez.   

Abstract

BACKGROUND: Current detection methods for Clostridium difficile infection (CDI) can be time-consuming and have variable sensitivities. Real-time polymerase chain reaction (PCR) may allow earlier and more accurate diagnosis of CDI than other currently available diagnostic tests. A meta-analysis was performed to determine the diagnostic accuracy of real-time PCR.
METHODS: We searched MEDLINE (Pubmed/Ovid) and 4 other online electronic databases (1995-2010) to identify diagnostic accuracy studies that compared PCR with cell culture cytotoxicity neutralization assay (CCCNA) or anaerobic toxigenic culture (TC) of C. difficile. Screening for inclusion, data extraction, and quality assessment were carried out independently by 2 investigators and disagreements resolved. Data were combined by means of a random-effects model, and summary receiver operating characteristic curves and diagnostic odds ratios were calculated.
RESULTS: Nineteen studies (7392 samples) met our inclusion criteria. The overall mean sensitivity of PCR was 90% (95% confidence interval [CI]: 88%-91%), specificity 96% (CI: 96%-97%), positive likelihood ratio 26.89 (CI: 20.81-34.74), negative likelihood ratio 0.11 (CI: .08-.15), diagnostic odds ratio 278.23 (CI: 213.56-362.50), and area under the curve 0.98 (CI: .98-.99). Test accuracy depended on the prevalence of C. difficile but not on the reference test used. At C. difficile prevalence of <10%, 10%-20% and >20% the positive predictive value and the negative predictive value were 71%, 79%, 93% and 99%, 98% and 96%, respectively.
CONCLUSIONS: Real-time PCR has a high sensitivity and specificity to confirm CDI. Overall diagnostic accuracy is variable and depends on CDI prevalence.

Entities:  

Mesh:

Year:  2011        PMID: 21890762     DOI: 10.1093/cid/cir505

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  33 in total

Review 1.  Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.

Authors:  John C O'Horo; Amy Jones; Matthew Sternke; Christopher Harper; Nasia Safdar
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

2.  Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.

Authors:  Rémi Le Guern; Stéphanie Herwegh; Bruno Grandbastien; René Courcol; Frédéric Wallet
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

Review 3.  Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.

Authors:  Nira R Pollock
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

4.  Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.

Authors:  Lance R Peterson; Stephen A Young; Thomas E Davis; Zi-Xuam Wang; John Duncan; Christopher Noutsios; Oliver Liesenfeld; John C Osiecki; Michael A Lewinski
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

5.  Clostridium difficile: the emerging epidemic.

Authors:  Nasia Safdar
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

6.  Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.

Authors:  Jennie H Kwon; Kimberly A Reske; Tiffany Hink; C A Burnham; Erik R Dubberke
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

7.  A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.

Authors:  Shik Luk; Wing Kin To; Tak Keung Ng; Wai Ting Hui; Wing Keung Lee; Florence Lau; Almond Man Wai Ching
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

8.  Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.

Authors:  Dipesh Solanky; Darrell S Pardi; Edward V Loftus; Sahil Khanna
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

Review 9.  Host response to Clostridium difficile infection: Diagnostics and detection.

Authors:  Elena A Usacheva; Jian-P Jin; Lance R Peterson
Journal:  J Glob Antimicrob Resist       Date:  2016-09-20       Impact factor: 4.035

10.  Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.

Authors:  Anna K Barker; Oguzhan Alagoz; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.